Park Ha Biological Stock Net Asset
| PHH Stock | 5.93 0.69 13.17% |
Park Ha Biological fundamentals help investors to digest information that contributes to Park Ha's financial success or failures. It also enables traders to predict the movement of Park Stock. The fundamental analysis module provides a way to measure Park Ha's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Park Ha stock.
Park | Net Asset |
Park Ha Biological Company Net Asset Analysis
Park Ha's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Park Ha Net Asset | 2.26 M |
Most of Park Ha's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Park Ha Biological is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Park Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Park Ha is extremely important. It helps to project a fair market value of Park Stock properly, considering its historical fundamentals such as Net Asset. Since Park Ha's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Park Ha's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Park Ha's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Park Total Assets
Total Assets |
|
Based on the recorded statements, Park Ha Biological has a Net Asset of 2.26 M. This is much higher than that of the Thrifts & Mortgage Finance sector and significantly higher than that of the Financials industry. The net asset for all United States stocks is notably lower than that of the firm.
Park Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Park Ha's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Park Ha could also be used in its relative valuation, which is a method of valuing Park Ha by comparing valuation metrics of similar companies.Park Ha is currently under evaluation in net asset category among its peers.
Park Fundamentals
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 139 M | ||||
| Shares Outstanding | 26.2 M | ||||
| Shares Owned By Insiders | 81.70 % | ||||
| Number Of Shares Shorted | 2.78 K | ||||
| Price To Earning | (4.59) X | ||||
| Price To Book | 131.00 X | ||||
| Price To Sales | 76.83 X | ||||
| Revenue | 2.46 M | ||||
| Gross Profit | 1.66 M | ||||
| EBITDA | 1.2 M | ||||
| Net Income | 852.04 K | ||||
| Cash And Equivalents | 455 M | ||||
| Cash Per Share | 6.25 X | ||||
| Total Debt | 31.46 K | ||||
| Debt To Equity | 125.70 % | ||||
| Current Ratio | 6.73 X | ||||
| Book Value Per Share | 0.04 X | ||||
| Cash Flow From Operations | 126.54 K | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | 0.02 X | ||||
| Price To Earnings To Growth | (4.39) X | ||||
| Target Price | 15.0 | ||||
| Number Of Employees | 33 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 149.08 M | ||||
| Total Asset | 2.26 M | ||||
| Retained Earnings | (105.23 K) | ||||
| Working Capital | 933.24 K | ||||
| Current Asset | 1.06 B | ||||
| Current Liabilities | 1.31 B | ||||
| Net Asset | 2.26 M |
About Park Ha Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Park Ha Biological's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Park Ha using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Park Ha Biological based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Park Ha Biological offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Park Ha's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Park Ha Biological Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Park Ha Biological Stock:Check out Park Ha Piotroski F Score and Park Ha Altman Z Score analysis. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Thrifts & Mortgage Finance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Park Ha. If investors know Park will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Park Ha listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.90) | Earnings Share 0.02 | Revenue Per Share | Quarterly Revenue Growth (0.38) |
The market value of Park Ha Biological is measured differently than its book value, which is the value of Park that is recorded on the company's balance sheet. Investors also form their own opinion of Park Ha's value that differs from its market value or its book value, called intrinsic value, which is Park Ha's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Park Ha's market value can be influenced by many factors that don't directly affect Park Ha's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Park Ha's value and its price as these two are different measures arrived at by different means. Investors typically determine if Park Ha is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Park Ha's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.